Embryonal Tumor with Multilayered Rosettes
Symptoms, Doctors, Treatments, Advances & More

Embryonal Tumor with Multilayered Rosettes Overview

Save information for later
Sign Up

Learn About Embryonal Tumor with Multilayered Rosettes

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Embryonal Tumor with Multilayered Rosettes Local Doctors?
Elite in Embryonal Tumor with Multilayered Rosettes
Elite in Embryonal Tumor with Multilayered Rosettes
Referral may be required

Duke Children's Health Center Hematology/Oncology Clinic

2301 Erwin Rd, 
Durham, NC 
Experience:
41+ years
Languages Spoken:
English

Susan Kreissman is a Pediatrics provider practicing medicine in Durham, North Carolina. She has been practicing medicine for over 41 years. Dr. Kreissman is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kreissman is board certified in American Board Of Pediatrics, Pediatric Hematology-Oncology.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Psychiatry | Neurology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Psychiatry | Neurology
Referral required

Advocate Medical Group Neurosurgery

3551 Highland Ave Ste, Ste 200A, 
Downers Grove, IL 
Languages Spoken:
English

Nina Paleologos is a Psychiatrist and a Neurologist practicing medicine in Downers Grove, Illinois. Dr. Paleologos is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Oligodendroglioma, Glioma, Glioblastoma, and Astrocytoma. Dr. Paleologos is board certified in American Board Of Psychiatry & Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Embryonal Tumor with Multilayered Rosettes
Hematology | Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Hematology | Oncology
Referral may be required

Atrium Health Levine Children’s Cancer & Blood Disorders, A Facility Of Carolinas Medical Center

1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
Experience:
25+ years
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Javier Oesterheld is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. He has been practicing medicine for over 25 years. Dr. Oesterheld is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Ewing Sarcoma, Osteosarcoma, and Bone Marrow Transplant. Dr. Oesterheld is board certified in American Board Of Pediatrics, Pediatric Hematology And Oncology and American Board Of Pediatrics. Dr. Oesterheld is currently accepting new patients.

What are the latest Embryonal Tumor with Multilayered Rosettes Clinical Trials?
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma

Summary: This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles of multi-agent chemotherapy. Naxitamab will be added to all 5 Induction cycles. We hypothesize that the addition of anti-GD2 therapy to induction chem...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Multi-center Phase I/II Clinical Trial of 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Summary: The purpose of this clinical trial is to assess the feasibility, safety and efficacy of multiple 4SCAR-T cell therapy which targets GD2, PSMA and CD276 surface antigens in patients with relapsed and refractory neuroblastoma (NB). Another goal of the study is to understand the function of the multi-CAR-T cells and their persistency in the patients.